Kevin H. Roche, Director at COGENTIX MEDICAL INC /DE/ (CGNT), bought 10,000 shares at $1.60 ($17K) on 2015-05-21, disclosed to the SEC on 2015-05-22.
Open-market purchase of $17k CGNT by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.59 | 300 | $477 | 2.8% |
| 2 | $1.60 | 700 | $1K | 6.7% |
| 3 | $1.63 | 1,500 | $2K | 14.5% |
| 4 | $1.70 | 3,500 | $6K | 35.3% |
| 5 | $1.71 | 4,000 | $7K | 40.6% |
| Total | $1.68 avg | 10,000 |
| $17K |
| 100% |
| Filing → |
| TCMD | SELL | 2019-05-13 | $1.2M | — | Filing → |
| TCMD | SELL | 2018-08-13 | $1.7M | — | Filing → |
| TCMD | SELL | 2018-05-14 | $666K | — | Filing → |